Convolution method to predict drug concentration profiles of 2,3,5,6-tetramethylpyrazine following transdermal application

International Journal of Pharmaceutics

Volumn 259, Issue 1-2, 2003, Pages 39-45

  Qi, Xiaohong ^a   Liu, Rong ^a   Sun, Duxin ^a   Ackermann, Chrisita ^b   Hou, Huimin ^c  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Shanghai Institute of Pharmaceutical Industry   (China)

Author keywords

Convolution; In vitro skin permeation; In vivo drug absorption; Transdermal delivery systems

Indexed keywords

TETRAMETHYLPYRAZINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DIFFUSION; DRUG PENETRATION; DRUG RELEASE; IN VITRO STUDY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RABBIT; SKIN PERMEABILITY; SYSTEMIC CIRCULATION;

EID: 0038700505     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00184-4     Document Type: Article

References (23)

1. Bensky, D., Gamble, A., 1993. Chinese Herbal Medicine: Materia Medica, Revised ed. Eastland Press, Seattle, WA.
2. Brown L., Langer R. Transdermal delivery of drugs. Ann. Rev. Med. 39:1988;221-229.
3. Burns J.W., Goodpasture J.C., Friel P., Wheeler R., Zaneveld L.J. Development and evaluation of an inhibitor-releasing matrix for intrauterine devices. Contraception. 26:1982;521-533.
4. Cai W., Dong S.N., Lou Y.Q. HPLC determination of tetramethylpyrazine in human serum and its pharmacokinetic parameters. Acta Pharmaceutica Sinica. 24:1989;881-886.
5. Chen K.J., Chen K. Clinical features and investigation of traditional Chinese medicine. Chin. Med. J. (English). 106:1993;403-405.
6. Culter D. Linear systems analysis in pharmaceutics. J. Pharmacokinet. Biopharm. 6:1978;227-241.
7. EMEA, 1999. Human Medicines Evaluation Unit. Note for Guidance on Quality of Modified Release Products: A. Oral Dosage Forms; B. Transdermal Dosage Forms; Section I (Quality). The European Agency for the Evaluation of Medicinal Products (EMEA) CPMP/QWP/604/96.
8. Flynn G.L., Stewart B. Percutaneous drug penetration choosing candidates for transdermal development. Drug. Dev. Res. 13:1988;169-185.
9. Flynn G.L., Shah V.P., Tenjarla S.N., Corbo M., DeMagistris D., Feldman T.G., Franz T.G., Miran D.R., Pearce D.M., Sequeira J.A., Swarbrick J., Wang J.C., Yacobi A., Zatz J.L. Assessment of value and applications of in vitro testing of topical dermatological drug products. Pharm. Res. 16:1999;1325-1330.
10. Lesser G.J., Grossman S.A., Leong K.W., Lo H., Eller S. In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain. Pain. 65:1996;265-272.
11. Gillespie W.R. Convolution-based approaches for in vivo-in vitro correlation modeling. Adv. Exp. Med. Biol. 423:1997;53-65.
12. Guo S.K., Chen K.J., Qian Z.H., Weng W.L., Qian M.Y. Tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases. Planta Med. 47:1983;89.
13. Guy R.H., Hadgraft J. The prediction of plasma levels of drugs following transdermal application. J. Control Release. 1:1985;177-182.
14. Guy R.H., Hadgraft J. Interpretation and prediction of the kinetics of transdermal drug delivery: oestradiol, hyoscine and timolol. Int. J. Pharm. 32:1986;159-163.
15. Guy, R.H., Hadgraft, J., 1989. Selection of drug candidates for transdermal delivery. In: J. Hadgraft, J., Guy, R.H. (Eds.), Transdermal Drug Delivery. Development Issues and Research Initiatives. Marcel Dekker, New York, pp. 59-81.
16. Ho W.K., Wen H.L., Lee C.M. Tetramethylpyrazine for treatment of experimentally induced stroke in Mongolian gerbils. Stroke. 20:1989;96-99.
17. Qi, X.H., 1999. In vitro and in vivo skin permeation study of Chuanxiong. Ph.D. thesis, Shanghai Institute of Industrial Pharmaceutics, Shanghai, China (in Chinese with English abstract).
18. Qi, X.H., Hou, H.M., 1997. Transdermal delivery system of tetramethylpyrzaine: the influence of varied EVA copolymer membrane on skin permeation of TMP. In: CRS-CPA Joint Workshop on Recent Advances in Drug Delivery Science and Technology, Beijing, 20-22 September 1997, 48 pp.
19. Ojewole J.A.O., Odebiyi O.O. Neuromuscular and cardiovascular actions of tetramethylpyrazine from the stem of Jatropha podagrica. Planta Med. 38:1980;332-338.
20. Roy S.D., Gutierrez M., Flynn G.L., Cleary G.W. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design. J. Pharm. Sci. 85:1996;491-495.
21. Veng-Pedersen P. Noncompartmentally-based pharmacokinetic modeling. Adv. Drug Deliv. Rev. 48:2001;265-300.
22. Shah V.P., Behl C.R., Flynn G.L., Higuchi W.I., Shaefer H. Principles and criteria in the development and optimization of topical therapeutic products. Pharm. Res. 9:1992;1107-1111.
23. U.S. Pharmacopoeia, 1995. U.S. Pharmacopoeia XXII, Rockville, MD, 1582 pp.